Skip to main content
. 2022 Jul 1;11(3):1341–1352. doi: 10.1007/s40120-022-00379-z

Table 3.

Concordance between subjective and objective assessments of AD severity by select symptoms and comorbidities

Concordant assessments, n (%) Discordant assessments, n (%)
S = O S < O S > O
Symptoms
 Wander 77 (73.3%) 17 (16.2%) 11 (10.5%)
 Aberrant motor 60 (67.4%) 12 (13.5%) 17 (19.1%)
 Hallucination 103 (56.0%) 43 (23.4%) 38 (20.7%)
 Apathy 14 (53.9%) 6 (23.1%) 6 (23.1%)
 Delirium 148 (51.2%) 106 (36.7%) 35 (12.1%)
 Irritability 46 (50.6%) 30 (33.0%) 15 (16.5%)
 Disorientation 71 (47.0%) 63 (41.7%) 17 (11.3%)
 Agitation/aggression 57 (39.9%) 66 (46.2%) 20 (14.0%)
 Delusion 26 (20.8%) 88 (70.4%) 11 (8.8%)
Comorbidities
 Type 1 diabetes 95 (60.5%) 42 (26.8%) 20 (12.7%)
 Graves’ disease 57 (58.8%) 22 (22.7%) 18 (18.6%)
 PTSD 654 (56.0%) 308 (26.4%) 205 (17.6%)
 Anxiety 1000 (55.1%) 548 (30.2%) 268 (14.8%)
 Sleep disorder 1352 (55.1%) 674 (27.5%) 426 (17.4%)
 Anemia 359 (53.2%) 196 (29.0%) 120 (17.8%)
 Rheumatoid disease 79 (49.7%) 32 (20.1%) 48 (30.2%)
 Bipolar/mania 573 (49.4%) 375 (32.4%) 211 (18.2%)
 Colitis 117 (48.8%) 65 (27.1%) 58 (24.2%)
 Eating disorder 66 (46.5%) 46 (32.4%) 30 (21.1%)
 Thrombocytopenia 58 (43.9%) 46 (34.9%) 28 (21.2%)
 Schizophrenia 50 (42.0%) 36 (30.3%) 33 (27.7%)
 Crohn’s disease 11 (34.4%) 7 (21.9%) 14 (43.8%)
 Celiac disease 6 (33.3%) 11 (61.1%) 1 (5.6%)

PTSD post-traumatic stress disorder